NCT05767047 - A Study of Apremilast in Children With Oral Ulcers Associated With Behçet's Disease or Juvenile Psoriatic Arthritis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 23, 2023

Primary Completion Date

March 17, 2036

Study Completion Date

March 17, 2036

Conditions

Behçet's DiseaseJuvenile Psoriatic Arthritis

Interventions

DRUG

Apremilast

Oral tablets or liquid suspension

Trial Locations (7)

RECRUITING

Hospital Universitario Ramon y Cajal, Madrid

RECRUITING

Istanbul Universitesi Cerrahpasa Tip Fakultesi, Istanbul

RECRUITING

Umraniye Egitim ve Arastirma Hastanesi, Istanbul

RECRUITING

Hospital Universitari i Politecnic La Fe, Valencia

RECRUITING

General Hospital of Thessaloniki Ippokrateio, Thessaloniki

RECRUITING

Meir Medical Center, Kfar Saba

RECRUITING

Hacettepe Universitesi Tip Fakultesi Hastanesi, Ankara